Abzena PLC’s (ABZA) Buy Rating Reiterated at FinnCap
FinnCap reaffirmed their buy rating on shares of Abzena PLC (LON:ABZA) in a report issued on Wednesday morning, StockTargetPrices.com reports. FinnCap currently has a GBX 80 ($1.03) price objective on the stock.
Separately, Numis Securities Ltd restated a buy rating and set a GBX 93 ($1.20) price objective on shares of Abzena PLC in a research report on Friday, May 26th.
Shares of Abzena PLC (ABZA) opened at 45.50 on Wednesday. The stock’s 50 day moving average is GBX 47.49 and its 200-day moving average is GBX 40.90. Abzena PLC has a 52-week low of GBX 31.00 and a 52-week high of GBX 66.00. The firm’s market cap is GBX 62.72 million.
About Abzena PLC
Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.
Receive News & Ratings for Abzena PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.